Search
Heart Diseases Clinical Trials
A listing of 38 Heart Diseases clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
37 - 38 of 38
There are currently 38 active clinical trials seeking participants for Heart Diseases research studies. The states with the highest number of trials for Autism participants are New York, Pennsylvania, California and Texas.
Featured Trial
Cardiovascular Disease Clinical Trials
Recruiting
Enroll in a clinical trial now and move closer to discovering an improved solution tailored for you. Receive compensation for your participation, along with free medical treatment.
Conditions:
Cardiovascular Diseases
Cardiovascular Disease
Coronary Artery Disease
Heart Failure
Arrhythmia
Featured Trial
55+ Obesity and Cardiovascular Disease Clinical Study
Recruiting
Diagnosed with cardiovascular disease? Join our local overweight with cardiovascular issues clinical trial. Every 34 seconds, someone in the US dies of cardiovascular disease. Wonder how you could help? If you’re eligible for our CVD clinical trial, you could receive up to $1500.
Conditions:
Obesity
Overweight and Obesity
Cardiovascular Disease
Cardiovascular Diseases
Cardiovascular Health
A Single-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Recruiting
To collect, preserve, and/or distribute annotated biospecimens and associated medical data to institutionally approved, investigator-directed biomedical research to discover and develop new treatments, diagnostics, and preventative methods for specific and complex conditions.
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
11/22/2022
Locations: Sanguine Biosciences, Waltham, Massachusetts
Conditions: Age-Related Macular Degeneration, Allergies, Alpha-Gal Syndrome, Alzheimer Disease, Amyloidosis, Ankylosing Spondylitis, Arthritis, Alopecia Areata, Asthma, Atopic Dermatitis, Autism, Autoimmune Hepatitis, Behcet's Disease, Beta-Thalassemia, Cancer, Celiac Disease, Kidney Diseases, COPD, Crohn Disease, Cystic Fibrosis, Diabetes, Dravet Syndrome, DMD, Fibromyalgia, Graves Disease, Thyroid Diseases, Hepatitis, Hidradenitis Suppurativa, ITP, Leukemia, ALS, Lupus or SLE, Lymphoma, Multiple Sclerosis, Myasthenia Gravis, Heart Diseases, Parkinson Disease, Pemphigus Vulgaris, Cirrhosis, Psoriasis, Schizophrenia, Scleroderma, Sickle Cell Disease, Stroke, Ulcerative Colitis, Vasculitis, Vitiligo
Evaluation of CCR2 in Patients Post Myocardial Infarction
Recruiting
To determine the feasibility of 64Cu-DOTA-ECL1i, an investigational PET imaging drug, at the cellular level in the myocardium for individuals who have suffered a heart attack or who have other inflammatory heart disease.
Gender:
All
Ages:
Between 21 years and 80 years
Trial Updated:
11/22/2022
Locations: Washington University School of Medicine, Saint Louis, Missouri
Conditions: Heart Diseases
37 - 38 of 38